In vitro effect of insulin on peripheral T lymphocyte E rosette function from normal and diabetic subjects

R. Cattaneo, V. Saibene, A. Margonato, G. Pozza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Juvenile-onset diabetics (JOD) have a significantly low peripheral T-lymphocyte count. In vitro exposure of diabetic lymphocyte cultures to insulin causes a significant T-cell count increase and thereafter no significant difference is detectable among JOD, maturity-onset diabetic (MOD) and normal subject (NS) T-cell counts. This finding supports the hypothesis that the T-lymphocyte depressed function present in JOD is a secondary phenomenon due to in vivo insulin deficiency. Possible mechanisms of insulin action in restoring E-rosette function are discussed.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalBollettino dell'Istituto Sieroterapico Milanese
Volume56
Issue number2
Publication statusPublished - 1977

Fingerprint

Insulin
T-Lymphocytes
Cell Count
Lymphocyte Count
Lymphocytes
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology

Cite this

In vitro effect of insulin on peripheral T lymphocyte E rosette function from normal and diabetic subjects. / Cattaneo, R.; Saibene, V.; Margonato, A.; Pozza, G.

In: Bollettino dell'Istituto Sieroterapico Milanese, Vol. 56, No. 2, 1977, p. 139-143.

Research output: Contribution to journalArticle

@article{06d7d61791f0455eb7d2930d45d7ca72,
title = "In vitro effect of insulin on peripheral T lymphocyte E rosette function from normal and diabetic subjects",
abstract = "Juvenile-onset diabetics (JOD) have a significantly low peripheral T-lymphocyte count. In vitro exposure of diabetic lymphocyte cultures to insulin causes a significant T-cell count increase and thereafter no significant difference is detectable among JOD, maturity-onset diabetic (MOD) and normal subject (NS) T-cell counts. This finding supports the hypothesis that the T-lymphocyte depressed function present in JOD is a secondary phenomenon due to in vivo insulin deficiency. Possible mechanisms of insulin action in restoring E-rosette function are discussed.",
author = "R. Cattaneo and V. Saibene and A. Margonato and G. Pozza",
year = "1977",
language = "English",
volume = "56",
pages = "139--143",
journal = "Bollettino dell'Istituto Sieroterapico Milanese",
issn = "0021-2547",
number = "2",

}

TY - JOUR

T1 - In vitro effect of insulin on peripheral T lymphocyte E rosette function from normal and diabetic subjects

AU - Cattaneo, R.

AU - Saibene, V.

AU - Margonato, A.

AU - Pozza, G.

PY - 1977

Y1 - 1977

N2 - Juvenile-onset diabetics (JOD) have a significantly low peripheral T-lymphocyte count. In vitro exposure of diabetic lymphocyte cultures to insulin causes a significant T-cell count increase and thereafter no significant difference is detectable among JOD, maturity-onset diabetic (MOD) and normal subject (NS) T-cell counts. This finding supports the hypothesis that the T-lymphocyte depressed function present in JOD is a secondary phenomenon due to in vivo insulin deficiency. Possible mechanisms of insulin action in restoring E-rosette function are discussed.

AB - Juvenile-onset diabetics (JOD) have a significantly low peripheral T-lymphocyte count. In vitro exposure of diabetic lymphocyte cultures to insulin causes a significant T-cell count increase and thereafter no significant difference is detectable among JOD, maturity-onset diabetic (MOD) and normal subject (NS) T-cell counts. This finding supports the hypothesis that the T-lymphocyte depressed function present in JOD is a secondary phenomenon due to in vivo insulin deficiency. Possible mechanisms of insulin action in restoring E-rosette function are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0017734320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017734320&partnerID=8YFLogxK

M3 - Article

C2 - 326272

AN - SCOPUS:0017734320

VL - 56

SP - 139

EP - 143

JO - Bollettino dell'Istituto Sieroterapico Milanese

JF - Bollettino dell'Istituto Sieroterapico Milanese

SN - 0021-2547

IS - 2

ER -